Longeveron Announces 1-for-10 Reverse Stock Split, Expected To Become Effective August 26
Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company will
A company called Longeveron is doing a reverse stock split—combining 10 old shares into 1 new share. This is often a sign the company's stock price has dropped, and they're trying to make it look better on paper.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.